RFA
TEVA icon

Reilly Financial Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Reilly Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Buy
+50
New +$451 ﹤0.01% 1204
2019
Q4 		– Sell
-500
Closed -$3K – 925
2019
Q3 		$3K Hold
500
– – ﹤0.01% 806
2019
Q2 		$5K Hold
500
– – ﹤0.01% 781
2019
Q1 		$8K Hold
500
– – ﹤0.01% 733
2018
Q4 		$8K Hold
500
– – ﹤0.01% 689
2018
Q3 		$11K Sell
500
-4,000
-89% -$92.9K ﹤0.01% 678
2018
Q2 		$109K Hold
4,500
– – 0.02% 210
2018
Q1 		$77K Hold
4,500
– – 0.01% 252
2017
Q4 		$85K Sell
4,500
-1,000
-18% -$15K 0.01% 259
2017
Q3 		$97K Hold
5,500
– – 0.01% 217
2017
Q2 		$183K Hold
5,500
– – 0.03% 158
2017
Q1 		$176K Buy
5,500
+5,000
+1,000% +$171K 0.03% 157
2016
Q4 		$18K Sell
500
-100
-17% -$3.99K ﹤0.01% 469
2016
Q3 		$28K Sell
600
-85
-12% -$4.43K 0.01% 353
2016
Q2 		$34K Hold
685
– – 0.01% 306
2016
Q1 		$37K Hold
685
– – 0.01% 439
2015
Q4 		$45K Sell
685
-600
-47% -$37.1K 0.01% 412
2015
Q3 		$73K Buy
1,285
+85
+7% +$5.51K 0.01% 314
2015
Q2 		$71K Sell
1,200
-400
-25% -$24.7K 0.01% 358
2015
Q1 		$100K Hold
1,600
– – 0.02% 276
2014
Q4 		$92K Buy
1,600
+461
+40% +$25.7K 0.02% 197
2014
Q3 		$61K Hold
1,139
– – 0.01% 232
2014
Q2 		$61K Buy
1,139
+500
+78% +$25.6K 0.01% 237
2014
Q1 		$34K Sell
639
-210
-25% -$9.71K 0.01% 338
2013
Q4 		$34K Buy
849
+80
+10% +$3.15K 0.01% 310
2013
Q3 		$29K Sell
769
-1,716
-69% -$66.9K 0.01% 295
2013
Q2 		$97K Buy
+2,485
New +$96.8K 0.03% 143

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Reilly Financial Advisors's TEVA Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q4 2021: 50 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1204 among its holdings. This is a return to the name: Reilly Financial Advisors previously reported a position in TEVA as recently as Q3 2019.

Reilly Financial Advisors first reported a position in TEVA in Q2 2013 and has held it in 27 quarters since. The position peaked at $183K in Q2 2017. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Reilly Financial Advisors held 50 shares of Teva Pharmaceutical Industries Limited worth $0 as of Q4 2021.
  • Teva Pharmaceutical Industries Limited was a new Reilly Financial Advisors position in Q4 2021.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #1204 holding.
  • Reilly Financial Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 27 quarters since.
  • Reilly Financial Advisors's Teva Pharmaceutical Industries Limited position peaked at $183K in Q2 2017.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.